Kirsten Nespithal
Director Safety Lead Risk Management BioNTech
Seminars
Thursday 29th January 2026
Comprehensive Safety Monitoring Across the mRNA Product Lifecycle from Clinical Development to Post-Marketing
11:30 am
- Understand best practices of safety monitoring during clinical trials to ensure robust safety oversight
- Learn how post-marketing studies and close interaction with health authorities shape ongoing patient safety and regulatory compliance.
